In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Semaia Pharmaceuticals

Division of Hybrigenics SA
www.semaia.com

Latest From Semaia Pharmaceuticals

How the Fund-Raising Game Works in Europe

A handful of private European biotechs have raised money, but the process takes time, and the sums aren't great. Since VCs can invest in late-stage companies at the same prices they used to pay for newer ventures, early and mid-stage biotechs are being forced to broaden their search for funds, and meet growing demands for cost cutting and detailed spending plans. Both VCs and biotechs may emerge stronger from the squeeze, however.
BioPharmaceutical Europe

Recent Dealmaking (06/2003)

Summarizing the month in European dealmaking.

Recent Dealmaking (10/2002)

Summarizing the month in European dealmaking.

Dealmaking (09/02)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Hybrigenics SA
  • Senior Management
  • Contact Info
  • Semaia Pharmaceuticals
    Phone: (49) 211 515 805 14
    Emil Figge Strasse 76
    Dortmund, D-44227
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register